{"gene":"LIMK2","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1995,"finding":"LIMK2 is a serine/threonine kinase with two N-terminal LIM motifs and a C-terminal kinase domain; it phosphorylates serine and threonine residues of exogenous substrates (e.g., myelin basic protein) in vitro, confirming its kinase activity.","method":"In vitro kinase assay with immunoprecipitated protein","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro kinase assay with immunoprecipitated protein, foundational study","pmids":["7651734"],"is_preprint":false},{"year":1997,"finding":"Recombinant LIMK2 is autophosphorylated and exhibits serine/threonine kinase activity toward exogenous substrate MBP; endogenous LIMK2 co-precipitates with a 140 kDa tyrosine-phosphorylated protein; LIMK2 localizes to both nucleus and Triton X-100 soluble cytoplasmic fraction.","method":"In vitro kinase assay; co-immunoprecipitation; subcellular fractionation","journal":"Journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro kinase assay plus Co-IP and fractionation in single study","pmids":["9089416"],"is_preprint":false},{"year":1996,"finding":"LIMK2a (with two LIM domains, PDZ domain, and kinase domain) is distributed in cytoplasm and nucleus, whereas LIMK2b (with one and a half LIM domains) is mainly cytoplasmic; a truncated LIMK2-Kinase construct localizes to the nucleus without showing protein association.","method":"Transfection and subcellular localization studies; Co-IP identifying associated 63 kDa and 58 kDa proteins","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct localization experiment with functional domain distinction and co-precipitation","pmids":["8954941"],"is_preprint":false},{"year":2005,"finding":"LIMK2 is a downstream effector of the Rho-ROCK pathway; loss of neurofibromin activates Rho-ROCK-LIMK2 signaling, increasing cofilin phosphorylation and actin stress fiber formation, thereby enhancing cell motility. This pathway requires Ras activation but is independent of Raf, PI3K, and RalGEF.","method":"siRNA knockdown of NF1; immunofluorescence; western blotting; genetic epistasis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — epistasis with multiple pathway branches tested, orthogonal methods, replicated pathway","pmids":["16169856"],"is_preprint":false},{"year":2005,"finding":"PKC-delta phosphorylates LIMK2 at Ser-283 (between PDZ and kinase domains), inhibiting nuclear import of LIMK2 in endothelial cells; this is a mechanism to relieve LIMK2-mediated suppression of cyclin D1 expression and promote G1-to-S transition.","method":"EGFP-LIMK2 live imaging; FRAP; leptomycin B treatment; in vitro phosphorylation by PKC-delta; site-directed mutagenesis (Ser-283)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro kinase assay with mutagenesis, live imaging, and FRAP in single study","pmids":["15923181"],"is_preprint":false},{"year":2006,"finding":"LIMK2 activity toward cofilin is markedly increased when cells are arrested in mitosis by microtubule disruption (nocodazole); LIMK2 localizes to the mitotic spindle during prometaphase and to the spindle midzone during anaphase/telophase, distinct from LIMK1's localization at spindle poles and the cleavage furrow.","method":"Immunofluorescence; cell synchronization with nocodazole; in vitro kinase assay","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 1–2 — direct kinase assay plus immunofluorescence localization with cell-cycle synchronization","pmids":["16455074"],"is_preprint":false},{"year":2010,"finding":"LIMK2 is a direct p53 target gene induced by genotoxic agents; activation of LIMK2 downstream of the RhoC-p53 axis has a pro-survival function following DNA damage, and LIMK inhibition sensitizes cells to radio- or chemotherapy.","method":"siRNA knockdown; pharmacological inhibition; ChIP (p53 target gene identification); cell viability assays","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing p53 transcriptional regulation and functional consequence","pmids":["21079653"],"is_preprint":false},{"year":2012,"finding":"Aurora A kinase directly phosphorylates LIMK2 at S283, T494, and T505, regulating LIMK2 kinase activity, subcellular localization, and protein levels; LIMK2 in turn positively regulates Aurora A levels (positive feedback loop); LIMK2 ablation fully abrogates Aurora-A-mediated tumorigenesis in vivo.","method":"Chemical genetic approach (analog-sensitive kinase); direct phosphorylation assays; site-directed mutagenesis; nude mouse xenograft","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1–2 — chemical genetics identifies direct substrate, mutagenesis confirms sites, in vivo validation","pmids":["22492986"],"is_preprint":false},{"year":2012,"finding":"LIMK2 acts downstream of RhoA-ROCK in regulating astral microtubule organization through TPPP (not cofilin), while both LIMK1 and LIMK2 affect centrosome focusing; these activities regulate spindle orientation in mitotic cells.","method":"RNAi knockdown; immunofluorescence; epistasis analysis","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — epistasis with multiple pathway branches, clean KO phenotype with specific cellular readout","pmids":["22328514"],"is_preprint":false},{"year":2012,"finding":"The NF1 RasGAP SecPH domain directly interacts with LIMK2 (but not LIMK1), partially inhibits LIMK2 kinase activity on cofilin, and specifically prevents LIMK2 activation by ROCK, establishing a cross-talk between Ras and Rho/ROCK/LIMK2/cofilin pathways.","method":"Yeast two-hybrid screen; co-immunoprecipitation; in vitro kinase assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — Y2H confirmed by Co-IP, mechanism tested by in vitro kinase assay, isoform specificity demonstrated","pmids":["23082153"],"is_preprint":false},{"year":2012,"finding":"LIMK2 is required for keratinocyte migration during eyelid development in vivo; LIMK2 knockout mice show eyes-open-at-birth phenotype due to failure of leading keratinocytes to nucleate filamentous actin, associated with reduced phospho-cofilin levels.","method":"LIMK2 knockout mouse; histology; immunostaining for F-actin and phospho-cofilin","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific in vivo phenotype and biochemical substrate readout","pmids":["23071748"],"is_preprint":false},{"year":2013,"finding":"LIMK2 deletion increases gastrointestinal stem cell proliferation in mice and Drosophila, revealing a conserved role for LIMK2 in constraining gastrointestinal stem cell homeostasis.","method":"Limk2 knockout mice; Drosophila LIMK knockdown; histology; mouse cancer model","journal":"Gut","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with defined cellular phenotype, cross-species validation","pmids":["23585469"],"is_preprint":false},{"year":2013,"finding":"Limk2 mediates Sema3A (but not Sema3F) signaling in cortical interneurons; Limk2 siRNA-transfected interneurons are less responsive to Sema3A, leading to aberrant invasion of the developing striatum.","method":"siRNA knockdown; chemotactic assays; brain slice preparation; in utero electroporation","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo electroporation and slice assays, multiple readouts, single lab","pmids":["23519094"],"is_preprint":false},{"year":2008,"finding":"ROCK1 directly interacts with LIMK2 (preferred substrate for ROCK1) in polarized/spread cancer cells but not in blebbing cells, as demonstrated by FRET; LIMK2 does not induce membrane blebbing, indicating the ROCK1:LIMK2 pathway is specific to mesenchymal-mode migration.","method":"FRET; Co-IP; functional migration assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — reciprocal FRET and Co-IP demonstrating direct interaction with spatial specificity","pmids":["18852895"],"is_preprint":false},{"year":2019,"finding":"LIMK2 directly phosphorylates TWIST1, stabilizing it; TWIST1 also stabilizes LIMK2 by inhibiting its ubiquitylation; phosphorylation-dead TWIST1 acts as dominant negative and prevents EMT and tumor formation in vivo, establishing LIMK2-TWIST1 as a signaling axis in CRPC.","method":"In vitro phosphorylation; dominant-negative mutant; in vivo xenograft; ubiquitylation assay","journal":"Cancer letters","confidence":"High","confidence_rationale":"Tier 1–2 — direct phosphorylation assay, dominant-negative validation, in vivo confirmation","pmids":["30716360"],"is_preprint":false},{"year":2020,"finding":"LIMK2 phosphorylates PTEN at five sites, promoting its degradation and inhibiting its activity; PTEN in turn degrades LIMK2 in a feedback loop; LIMK2 is the missing link between hypoxia and PTEN degradation in CRPC.","method":"In vitro phosphorylation; site mapping; PTEN-/- and PTEN+/+ mouse prostates; xenograft","journal":"Cancer letters","confidence":"High","confidence_rationale":"Tier 1–2 — direct phosphorylation assay with site identification, confirmed in PTEN KO mice","pmids":["32931887"],"is_preprint":false},{"year":2020,"finding":"LIMK2 directly phosphorylates and degrades SPOP (E3 ubiquitin ligase adaptor) at three sites; SPOP in turn promotes LIMK2 ubiquitylation (feedback loop); SPOP degradation stabilizes AR, ARv7, and c-Myc; phospho-resistant SPOP completely suppresses tumorigenesis in vivo.","method":"Innovative direct target identification technique; in vitro phosphorylation; ubiquitylation assay; xenograft","journal":"British journal of cancer","confidence":"High","confidence_rationale":"Tier 1–2 — direct phosphorylation with site mapping, phospho-resistant mutant, in vivo validation","pmids":["33311589"],"is_preprint":false},{"year":2021,"finding":"NKX3.1 is directly phosphorylated and degraded by LIMK2; NKX3.1 in turn promotes LIMK2 ubiquitylation; this LIMK2-NKX3.1 feedback loop regulates AR, ARv7, and AKT signaling in CRPC.","method":"Direct phosphorylation assay; ubiquitylation assay; in vivo xenograft; biochemical assays","journal":"Cancers","confidence":"High","confidence_rationale":"Tier 1–2 — direct phosphorylation with feedback loop demonstrated, in vivo validation","pmids":["34066036"],"is_preprint":false},{"year":2020,"finding":"LIMK2 promotes TNBC metastasis through phosphorylation and activation of SRPK1 (serine/arginine protein kinase); LIMK2 inhibition blocks SRPK1 phosphorylation and activity, and pharmacological inhibition of LIMK2 blocks metastasis in mice without affecting primary tumor growth.","method":"SILAC-based phosphoproteomics; shRNA knockdown; pharmacological inhibition; in vivo metastasis model","journal":"Oncogenesis","confidence":"High","confidence_rationale":"Tier 1–2 — unbiased phosphoproteomics identifies substrate, confirmed by genetic/pharmacological inhibition in vivo","pmids":["32859889"],"is_preprint":false},{"year":2018,"finding":"The LIMK2-1 isoform contains a PP1 inhibitory domain at its C-terminus; it does not directly phosphorylate cofilin but interacts with PP1 and partially inhibits its activity toward cofilin, regulating actin cytoskeleton dynamics by preventing PP1-mediated cofilin dephosphorylation.","method":"Biochemical characterization; in vitro kinase assay; Co-IP with PP1; actin stress fiber assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro kinase assay demonstrates absence of cofilin phosphorylation, Co-IP demonstrates PP1 interaction, mechanistic alternative established","pmids":["30373762"],"is_preprint":false},{"year":2019,"finding":"LIMK1 and LIMK2 regulate cortical development by controlling neural progenitor cell proliferation and neuronal migration; LIMK2 KO mice show reduced pyramidal neurons in upper cortical layers with a smaller progenitor pool and impaired neuronal migration.","method":"LIMK2 knockout mice; histology; cell counting","journal":"Molecular brain","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with specific developmental phenotype, single lab","pmids":["31319858"],"is_preprint":false},{"year":2021,"finding":"LIMK2 is required for membrane cytoskeleton reorganization in airway smooth muscle; LIMK2 deletion causes ~30% inhibition of contractile force, reduced cofilin phosphorylation, decreased F/G-actin ratio, and abolishes stretching-induced suppression of 5-HT-evoked force; LIMK2 acts independently of cross-bridge movement.","method":"LIMK2 knockout mice; force transduction assays; F/G-actin ratio measurement; western blotting","journal":"Journal of genetics and genomics","confidence":"High","confidence_rationale":"Tier 2 — clean KO with quantitative functional readout and biochemical substrate measurement","pmids":["34353741"],"is_preprint":false},{"year":2015,"finding":"Endothelin-1 acts upstream of LIMK2 via ETB receptor and ROCK1 to induce programmed necrotic neuronal death; ET-1/ETB/ROCK1/LIMK2 signaling impairs DRP1-mediated mitochondrial fission, leading to neuronal necrosis.","method":"ETB receptor antagonist (BQ788); western blotting; in vivo status epilepticus model","journal":"Molecular brain","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological antagonism defines pathway position, in vivo model, single lab","pmids":["26438559"],"is_preprint":false},{"year":2017,"finding":"BMPR2 directly interacts with LIMK2 and activates it through the RhoA/ROCK pathway; LIMK2 phosphorylation by BMPR2 is crucial for BMPR2-mediated pro-metastatic signaling in osteosarcoma cells.","method":"iTRAQ-based phosphoproteomic analysis; western blotting; Co-IP (direct interaction); in vivo orthotopic model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP for direct interaction, phosphoproteomics, in vivo validation, single lab","pmids":["28938584"],"is_preprint":false},{"year":2025,"finding":"LIMK2 phosphorylates MST4 at threonine 178 (T178), activating its kinase function; activated MST4 then phosphorylates NPM1 at T95, which is essential for centrosome clustering and tumor cell proliferation; LIMK2 knockout significantly attenuates esophageal tumorigenesis in vivo.","method":"In vitro kinase assay; site-specific mutagenesis; genetic depletion; in vivo 4NQO tumorigenesis model; pharmacological inhibition","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 — direct phosphorylation with site identification, cascade confirmed, in vivo validation","pmids":["40775397"],"is_preprint":false},{"year":2025,"finding":"LIMK2-1 isoform is phosphorylated predominantly by protein kinase C; phosphorylated LIMK2-1 inhibits PP1 catalytic subunit isoforms and the myosin phosphatase holoenzyme with IC50 ~28–47 nM, functioning as a CPI-17-like phosphatase inhibitor.","method":"Co-IP with PP1c isoforms; in vitro phosphatase inhibition assay; overexpression in tsA201 cells","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 1 — reconstituted phosphatase inhibition assay with IC50 determination, Co-IP confirms interaction","pmids":["40806479"],"is_preprint":false},{"year":2020,"finding":"LIMK2a knockout mice show prolonged bleeding and defects in platelet spreading, aggregation, and thrombus formation, demonstrating an essential role for LIMK2 in platelet actin cytoskeleton-dependent functions.","method":"LIMK2a knockout mouse; bleeding time assay; platelet spreading assay; aggregation assay","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 — clean isoform-specific KO with defined platelet functional phenotype, single lab","pmids":["31926945"],"is_preprint":false},{"year":2023,"finding":"LIMK2 phosphorylates G3BP1 as a key direct substrate; G3BP1 inhibition mirrors LIMK2 inhibition; G3BP1 regulates ESM1 mRNA stability downstream, defining a LIMK2→G3BP1→ESM1 pathway promoting melanoma growth and metastasis.","method":"Phosphoproteomics; shRNA knockdown; RNA-seq; mRNA stability assay; in vivo tumor model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 — phosphoproteomics identifies substrate, cascade validated by genetic tools and in vivo model","pmids":["36922679"],"is_preprint":false},{"year":2022,"finding":"Thromboxane A2 receptor activation signals through Gα13-RhoA/C-ROCK-LIMK2 to inhibit angiogenic sprouting of endothelial cells and induce endothelial cell contraction, tension, and focal adhesion dysregulation.","method":"RNAi-mediated silencing; pharmacological inhibition; FRET biosensors for RhoA/C; HUVEC spheroid sprouting assay","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — pathway established by RNAi epistasis plus FRET validation, single lab","pmids":["35525325"],"is_preprint":false}],"current_model":"LIMK2 is a serine/threonine kinase that acts downstream of RhoA-ROCK (and other upstream kinases including Aurora A and PKC-delta) to phosphorylate cofilin (inactivating it to stabilize actin filaments), and also directly phosphorylates multiple non-cofilin substrates including TWIST1, PTEN, SPOP, NKX3.1, SRPK1, G3BP1, and MST4, while its LIMK2-1 isoform instead inhibits PP1/myosin phosphatase; its subcellular localization and nuclear import are regulated by PKC-delta-mediated phosphorylation at Ser-283, and it plays defined roles in cell migration, mitotic spindle organization, gastrointestinal stem cell homeostasis, neuronal migration, platelet function, and airway smooth muscle contraction."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing LIMK2 as a bona fide serine/threonine kinase answered the fundamental question of whether this LIM-domain protein possessed intrinsic catalytic activity.","evidence":"In vitro kinase assay with immunoprecipitated LIMK2 phosphorylating MBP","pmids":["7651734"],"confidence":"High","gaps":["Physiological substrates unidentified","Upstream activators unknown","Relationship to actin cytoskeleton not established"]},{"year":1996,"claim":"Isoform-specific localization studies revealed that the LIM/PDZ domains control cytoplasmic vs. nuclear distribution, establishing that LIMK2 functions in multiple subcellular compartments.","evidence":"Transfection and localization of LIMK2a, LIMK2b, and kinase-only constructs with Co-IP","pmids":["8954941"],"confidence":"Medium","gaps":["Nuclear function undefined","Nuclear import mechanism unknown","Associated proteins at 63/58 kDa unidentified"]},{"year":2005,"claim":"Placing LIMK2 downstream of Rho-ROCK in a cofilin-phosphorylating cascade resolved its principal physiological pathway and linked it to actin stress fiber formation and cell motility.","evidence":"siRNA knockdown of NF1 with epistasis analysis separating Ras-Raf/PI3K/RalGEF from Rho-ROCK-LIMK2","pmids":["16169856"],"confidence":"High","gaps":["Direct ROCK-LIMK2 phosphorylation sites not mapped","Non-cofilin substrates unknown","In vivo relevance not demonstrated"]},{"year":2005,"claim":"Discovery that PKC-δ phosphorylates LIMK2 at Ser-283 to block nuclear import established a regulated mechanism for controlling LIMK2 subcellular distribution and cell cycle progression.","evidence":"In vitro phosphorylation by PKC-δ; Ser-283 mutagenesis; FRAP and live imaging of EGFP-LIMK2","pmids":["15923181"],"confidence":"High","gaps":["Nuclear substrates of LIMK2 not identified beyond cyclin D1 regulation","Whether Ser-283 phosphorylation affects kinase activity per se untested"]},{"year":2006,"claim":"Demonstration that LIMK2 localizes to the mitotic spindle and spindle midzone with increased cofilin kinase activity during mitosis extended its role beyond interphase actin regulation to cell division.","evidence":"Immunofluorescence with cell-cycle synchronization; in vitro kinase assay on mitotic extracts","pmids":["16455074"],"confidence":"High","gaps":["Mitotic LIMK2 activating kinase not identified at this point","Whether spindle localization requires cofilin phosphorylation unclear"]},{"year":2008,"claim":"FRET-based demonstration that ROCK1 preferentially interacts with LIMK2 in polarized/spread cells showed the ROCK1–LIMK2 axis is specific to mesenchymal-mode migration, not blebbing.","evidence":"FRET and Co-IP in cancer cells with distinct morphological modes","pmids":["18852895"],"confidence":"High","gaps":["ROCK2 vs. ROCK1 selectivity for LIMK2 not fully resolved","Structural basis of mesenchymal-specific interaction unknown"]},{"year":2010,"claim":"Identification of LIMK2 as a direct p53 target gene linked cytoskeletal remodeling to the DNA damage response, revealing a pro-survival role for LIMK2 after genotoxic stress.","evidence":"ChIP confirming p53 occupancy at LIMK2 promoter; siRNA and pharmacological inhibition sensitizing cells to radio/chemotherapy","pmids":["21079653"],"confidence":"High","gaps":["Precise p53-binding element not fine-mapped","Whether cofilin is the relevant substrate in this survival context unknown"]},{"year":2012,"claim":"Multiple studies converged to define LIMK2's in vivo roles: Aurora A directly phosphorylates and activates LIMK2 creating a positive feedback loop essential for tumorigenesis; LIMK2 regulates astral microtubules through TPPP; NF1 SecPH domain specifically inhibits LIMK2 (not LIMK1); and LIMK2 knockout causes eyes-open-at-birth due to failed keratinocyte migration.","evidence":"Chemical genetics (Aurora A analog-sensitive kinase); RNAi epistasis for TPPP; Y2H/Co-IP for NF1-LIMK2; LIMK2 knockout mouse phenotyping","pmids":["22492986","22328514","23082153","23071748"],"confidence":"High","gaps":["Whether Aurora A and ROCK phosphorylation of LIMK2 are cooperative or competitive","TPPP phosphorylation by LIMK2 not directly demonstrated","Structural basis of NF1 SecPH selectivity for LIMK2 over LIMK1 unknown"]},{"year":2013,"claim":"Loss-of-function studies in mice and Drosophila revealed a conserved role for LIMK2 in restraining gastrointestinal stem cell proliferation, and LIMK2 was shown to mediate Sema3A signaling in cortical interneurons for proper neuronal migration.","evidence":"LIMK2 knockout mice and Drosophila LIMK knockdown for GI homeostasis; siRNA and in utero electroporation for neuronal migration","pmids":["23585469","23519094"],"confidence":"High","gaps":["Downstream substrate in GI stem cells not identified","Whether cofilin or another substrate mediates Sema3A response unresolved"]},{"year":2018,"claim":"Characterization of the LIMK2-1 splice isoform revealed it lacks cofilin kinase activity and instead functions as a PP1 inhibitor, providing an entirely distinct mechanism for cytoskeletal regulation.","evidence":"In vitro kinase assay showing no cofilin phosphorylation; Co-IP with PP1; actin stress fiber assay","pmids":["30373762"],"confidence":"High","gaps":["Tissue distribution and expression ratio of LIMK2-1 vs. other isoforms incompletely defined","PP1 inhibitory domain not structurally characterized"]},{"year":2019,"claim":"Identification of TWIST1 as a direct LIMK2 substrate that reciprocally stabilizes LIMK2 revealed a kinase-transcription factor feedback axis driving EMT in castration-resistant prostate cancer.","evidence":"In vitro phosphorylation; phosphorylation-dead dominant-negative TWIST1; xenograft tumor assays","pmids":["30716360"],"confidence":"High","gaps":["Specific TWIST1 phosphorylation sites by LIMK2 not fully mapped","Whether this axis operates outside prostate cancer untested"]},{"year":2020,"claim":"A burst of substrate discovery established LIMK2 as a multi-substrate kinase: it phosphorylates and degrades PTEN and SPOP (each in feedback loops), activates SRPK1 to promote metastasis, and is required for platelet function in vivo.","evidence":"Direct in vitro phosphorylation with site mapping for PTEN and SPOP; SILAC phosphoproteomics for SRPK1; LIMK2a knockout mouse for platelet assays","pmids":["32931887","33311589","32859889","31926945"],"confidence":"High","gaps":["How LIMK2 substrate selectivity is determined (cofilin vs. non-cofilin targets) unknown","Whether PTEN/SPOP regulation occurs in non-prostate tissues untested","Platelet phenotype rescue experiments not performed"]},{"year":2021,"claim":"NKX3.1 was added as another LIMK2 substrate in a mutual degradation loop regulating AR signaling, while LIMK2 knockout studies demonstrated its requirement for airway smooth muscle contraction through cofilin-dependent actin remodeling.","evidence":"Direct phosphorylation and ubiquitylation assays for NKX3.1; LIMK2 KO mouse force transduction and F/G-actin ratio measurements","pmids":["34066036","34353741"],"confidence":"High","gaps":["Whether LIMK2 regulation of AR signaling depends on NKX3.1 phosphorylation alone or also on SPOP/PTEN degradation","Mechanism connecting cofilin to smooth muscle actin polymerization vs. myosin regulation not delineated"]},{"year":2023,"claim":"Phosphoproteomic identification of G3BP1 as a LIMK2 substrate linked LIMK2 to mRNA stability regulation through a LIMK2→G3BP1→ESM1 axis in melanoma.","evidence":"Phosphoproteomics; shRNA; RNA-seq; mRNA stability assay; in vivo melanoma model","pmids":["36922679"],"confidence":"High","gaps":["Whether G3BP1 phosphorylation by LIMK2 affects stress granule dynamics untested","Broader RNA targets beyond ESM1 not defined"]},{"year":2025,"claim":"Discovery that LIMK2 phosphorylates MST4 at T178 to activate a MST4→NPM1 cascade for centrosome clustering revealed a new mechanism for LIMK2-driven tumor proliferation, while quantitative IC50 measurements established LIMK2-1 as a nanomolar-potency myosin phosphatase inhibitor.","evidence":"In vitro kinase assay with site-specific mutagenesis and in vivo esophageal tumorigenesis model for MST4; reconstituted phosphatase inhibition assay with IC50 for LIMK2-1","pmids":["40775397","40806479"],"confidence":"High","gaps":["Whether LIMK2-MST4-NPM1 operates in non-esophageal cancers untested","Relative contribution of LIMK2-1 PP1 inhibition vs. canonical LIMK2 cofilin phosphorylation in vivo unknown"]},{"year":null,"claim":"How LIMK2 achieves substrate selectivity among its numerous substrates (cofilin, TWIST1, PTEN, SPOP, NKX3.1, SRPK1, G3BP1, MST4), whether there is a unifying structural or scaffold-based mechanism, and how isoform-specific functions (LIMK2a kinase vs. LIMK2-1 phosphatase inhibitor) are coordinated in vivo remain major open questions.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of LIMK2 in complex with any substrate","Isoform expression ratio across tissues not systematically mapped","No comprehensive phosphosite atlas of LIMK2 autophosphorylation or upstream regulation"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,3,5,7,14,15,16,17,18,24,27]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[19,25]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2,4]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,2]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[5,8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,8,9,13,22,23,28]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[5,7,8,24]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[10,12,20]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[22]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[14,15,16,17,18,27]}],"complexes":[],"partners":["CFL1","ROCK1","AURKA","TWIST1","PTEN","SPOP","PPP1CA","NF1"],"other_free_text":[]},"mechanistic_narrative":"LIMK2 is a LIM-domain-containing serine/threonine kinase that functions as a central integrator of Rho-ROCK, Aurora A, and PKC-δ signaling to regulate actin cytoskeleton dynamics, mitotic spindle organization, cell migration, and diverse transcriptional and signaling outputs. Its best-characterized activity is phosphorylation and inactivation of cofilin, which stabilizes F-actin and is required for keratinocyte migration, platelet function, airway smooth muscle contraction, cortical neuronal migration, and gastrointestinal stem cell homeostasis [PMID:23071748, PMID:31926945, PMID:34353741, PMID:31319858, PMID:23585469]. Beyond cofilin, LIMK2 directly phosphorylates substrates including TWIST1, PTEN, SPOP, NKX3.1, SRPK1, G3BP1, and MST4—often engaging in reciprocal feedback loops that control substrate stability—thereby driving epithelial-mesenchymal transition, androgen receptor signaling in castration-resistant prostate cancer, metastasis, and centrosome clustering [PMID:30716360, PMID:32931887, PMID:33311589, PMID:32859889, PMID:36922679, PMID:40775397]. The LIMK2-1 splice isoform lacks direct cofilin kinase activity and instead functions as a potent CPI-17-like inhibitor of PP1/myosin phosphatase upon PKC-mediated phosphorylation, providing an alternative mechanism for cytoskeletal regulation [PMID:30373762, PMID:40806479]."},"prefetch_data":{"uniprot":{"accession":"P53671","full_name":"LIM domain kinase 2","aliases":[],"length_aa":638,"mass_kda":72.2,"function":"Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics (PubMed:10436159, PubMed:11018042). Acts downstream of several Rho family GTPase signal transduction pathways (PubMed:10436159, PubMed:11018042). Involved in astral microtubule organization and mitotic spindle orientation during early stages of mitosis by mediating phosphorylation of TPPP (PubMed:22328514). Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro (PubMed:8537403). Suppresses ciliogenesis via multiple pathways; phosphorylation of CFL1, suppression of directional trafficking of ciliary vesicles to the ciliary base, and by facilitating YAP1 nuclear localization where it acts as a transcriptional corepressor of the TEAD4 target genes AURKA and PLK1 (PubMed:25849865)","subcellular_location":"Cytoplasm; Cytoplasm, perinuclear region; Nucleus","url":"https://www.uniprot.org/uniprotkb/P53671/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LIMK2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000182541","cell_line_id":"CID001190","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":1}],"interactors":[{"gene":"CDC37","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001190","total_profiled":1310},"omim":[{"mim_id":"607621","title":"COLLECTIN 12; COLEC12","url":"https://www.omim.org/entry/607621"},{"mim_id":"604746","title":"TESTIS-ASSOCIATED ACTIN-MODELING KINASE 2; TESK2","url":"https://www.omim.org/entry/604746"},{"mim_id":"601988","title":"LIM DOMAIN KINASE 2; LIMK2","url":"https://www.omim.org/entry/601988"},{"mim_id":"601782","title":"TESTIS-ASSOCIATED ACTIN-MODELING KINASE 1; TESK1","url":"https://www.omim.org/entry/601782"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/LIMK2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P53671","domains":[{"cath_id":"2.10.110.10","chopping":"11-67","consensus_level":"high","plddt":84.3586,"start":11,"end":67},{"cath_id":"2.30.42.10","chopping":"84-242","consensus_level":"medium","plddt":86.2718,"start":84,"end":242},{"cath_id":"3.30.200.20","chopping":"324-405","consensus_level":"high","plddt":80.1312,"start":324,"end":405},{"cath_id":"1.10.510.10","chopping":"410-476_503-629","consensus_level":"high","plddt":92.5202,"start":410,"end":629}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P53671","model_url":"https://alphafold.ebi.ac.uk/files/AF-P53671-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P53671-F1-predicted_aligned_error_v6.png","plddt_mean":76.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LIMK2","jax_strain_url":"https://www.jax.org/strain/search?query=LIMK2"},"sequence":{"accession":"P53671","fasta_url":"https://rest.uniprot.org/uniprotkb/P53671.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P53671/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P53671"}},"corpus_meta":[{"pmid":"7651734","id":"PMC_7651734","title":"LIMK-1 and LIMK-2, two members of a LIM motif-containing protein kinase family.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7651734","citation_count":86,"is_preprint":false},{"pmid":"20047470","id":"PMC_20047470","title":"LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells.","date":"2009","source":"Zebrafish","url":"https://pubmed.ncbi.nlm.nih.gov/20047470","citation_count":81,"is_preprint":false},{"pmid":"30886151","id":"PMC_30886151","title":"Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30886151","citation_count":68,"is_preprint":false},{"pmid":"21079653","id":"PMC_21079653","title":"p53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survival.","date":"2010","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/21079653","citation_count":68,"is_preprint":false},{"pmid":"16169856","id":"PMC_16169856","title":"The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16169856","citation_count":63,"is_preprint":false},{"pmid":"31695759","id":"PMC_31695759","title":"NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31695759","citation_count":51,"is_preprint":false},{"pmid":"22492986","id":"PMC_22492986","title":"LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22492986","citation_count":51,"is_preprint":false},{"pmid":"9149099","id":"PMC_9149099","title":"Comparison of tissue distribution of two novel serine/threonine kinase genes containing the LIM motif (LIMK-1 and LIMK-2) in the developing rat.","date":"1997","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9149099","citation_count":49,"is_preprint":false},{"pmid":"36899941","id":"PMC_36899941","title":"LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36899941","citation_count":41,"is_preprint":false},{"pmid":"16455074","id":"PMC_16455074","title":"Different activity regulation and subcellular localization of LIMK1 and LIMK2 during cell cycle transition.","date":"2006","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/16455074","citation_count":37,"is_preprint":false},{"pmid":"23082153","id":"PMC_23082153","title":"Nf1 RasGAP inhibition of LIMK2 mediates a new cross-talk between Ras and Rho pathways.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23082153","citation_count":34,"is_preprint":false},{"pmid":"32859889","id":"PMC_32859889","title":"LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1.","date":"2020","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/32859889","citation_count":34,"is_preprint":false},{"pmid":"29970879","id":"PMC_29970879","title":"Imbalanced LIMK1 and LIMK2 expression leads to human colorectal cancer progression and metastasis via promoting β-catenin nuclear translocation.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29970879","citation_count":34,"is_preprint":false},{"pmid":"30716360","id":"PMC_30716360","title":"Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.","date":"2019","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30716360","citation_count":32,"is_preprint":false},{"pmid":"22328514","id":"PMC_22328514","title":"TPPP acts downstream of RhoA-ROCK-LIMK2 to regulate astral microtubule organization and spindle orientation.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22328514","citation_count":31,"is_preprint":false},{"pmid":"33014879","id":"PMC_33014879","title":"VEGFR2 Promotes Metastasis and PD-L2 Expression of Human Osteosarcoma Cells by Activating the STAT3 and RhoA-ROCK-LIMK2 Pathways.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33014879","citation_count":30,"is_preprint":false},{"pmid":"23585469","id":"PMC_23585469","title":"Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation.","date":"2013","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/23585469","citation_count":29,"is_preprint":false},{"pmid":"25593987","id":"PMC_25593987","title":"Novel LIMK2 Inhibitor Blocks Panc-1 Tumor Growth in a mouse xenograft model.","date":"2014","source":"Oncoscience","url":"https://pubmed.ncbi.nlm.nih.gov/25593987","citation_count":29,"is_preprint":false},{"pmid":"8954941","id":"PMC_8954941","title":"Subcellular localization and protein interaction of the human LIMK2 gene expressing alternative transcripts with tissue-specific regulation.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8954941","citation_count":28,"is_preprint":false},{"pmid":"30006972","id":"PMC_30006972","title":"LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30006972","citation_count":27,"is_preprint":false},{"pmid":"16524786","id":"PMC_16524786","title":"Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.","date":"2006","source":"Vascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16524786","citation_count":26,"is_preprint":false},{"pmid":"28938584","id":"PMC_28938584","title":"BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28938584","citation_count":25,"is_preprint":false},{"pmid":"15923181","id":"PMC_15923181","title":"Inhibition of nuclear import of LIMK2 in endothelial cells by protein kinase C-dependent phosphorylation at Ser-283.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15923181","citation_count":25,"is_preprint":false},{"pmid":"31072327","id":"PMC_31072327","title":"MED12 exerts an emerging role in actin-mediated cytokinesis via LIMK2/cofilin pathway in NSCLC.","date":"2019","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31072327","citation_count":25,"is_preprint":false},{"pmid":"15467300","id":"PMC_15467300","title":"PDGF and IL-1beta upregulate cofilin and LIMK2 in canine cultured pulmonary artery smooth muscle cells.","date":"2004","source":"Journal of vascular research","url":"https://pubmed.ncbi.nlm.nih.gov/15467300","citation_count":23,"is_preprint":false},{"pmid":"31319858","id":"PMC_31319858","title":"LIMK1 and LIMK2 regulate cortical development through affecting neural progenitor cell proliferation and migration.","date":"2019","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/31319858","citation_count":22,"is_preprint":false},{"pmid":"9425257","id":"PMC_9425257","title":"cDNA cloning, genomic organization, and chromosomal localization of the mouse LIM motif-containing kinase gene, Limk2.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9425257","citation_count":22,"is_preprint":false},{"pmid":"26438559","id":"PMC_26438559","title":"Endothelin-1 induces LIMK2-mediated programmed necrotic neuronal death independent of NOS activity.","date":"2015","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/26438559","citation_count":20,"is_preprint":false},{"pmid":"32931887","id":"PMC_32931887","title":"Negative cross talk between LIMK2 and PTEN promotes castration resistant prostate cancer pathogenesis in cells and in vivo.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/32931887","citation_count":20,"is_preprint":false},{"pmid":"33311589","id":"PMC_33311589","title":"Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer.","date":"2020","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33311589","citation_count":20,"is_preprint":false},{"pmid":"23071748","id":"PMC_23071748","title":"Keratinocyte migration in the developing eyelid requires LIMK2.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23071748","citation_count":20,"is_preprint":false},{"pmid":"23991158","id":"PMC_23991158","title":"LIMK2 mediates resistance to chemotherapeutic drugs in neuroblastoma cells through regulation of drug-induced cell cycle arrest.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23991158","citation_count":20,"is_preprint":false},{"pmid":"10452946","id":"PMC_10452946","title":"Cloning and characterization of the alternative promoter regions of the human LIMK2 gene responsible for alternative transcripts with tissue-specific expression.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10452946","citation_count":20,"is_preprint":false},{"pmid":"30833597","id":"PMC_30833597","title":"Deletion of Limk1 and Limk2 in mice does not alter cochlear development or auditory function.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30833597","citation_count":19,"is_preprint":false},{"pmid":"34066036","id":"PMC_34066036","title":"LIMK2-NKX3.1 Engagement Promotes Castration-Resistant Prostate Cancer.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34066036","citation_count":18,"is_preprint":false},{"pmid":"18852895","id":"PMC_18852895","title":"ROCK1 and LIMK2 interact in spread but not blebbing cancer cells.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18852895","citation_count":18,"is_preprint":false},{"pmid":"25549868","id":"PMC_25549868","title":"Inhibition of FSS-induced actin cytoskeleton reorganization by silencing LIMK2 gene increases the mechanosensitivity of primary osteoblasts.","date":"2014","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/25549868","citation_count":17,"is_preprint":false},{"pmid":"18805530","id":"PMC_18805530","title":"Effect of LIMK2 RNAi on reorganization of the actin cytoskeleton in osteoblasts induced by fluid shear stress.","date":"2008","source":"Journal of biomechanics","url":"https://pubmed.ncbi.nlm.nih.gov/18805530","citation_count":17,"is_preprint":false},{"pmid":"9089416","id":"PMC_9089416","title":"Cloning and biochemical characterization of LIMK-2, a protein kinase containing two LIM domains.","date":"1997","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9089416","citation_count":16,"is_preprint":false},{"pmid":"23881296","id":"PMC_23881296","title":"Theoretical study on the interaction of pyrrolopyrimidine derivatives as LIMK2 inhibitors: insight into structure-based inhibitor design.","date":"2013","source":"Molecular bioSystems","url":"https://pubmed.ncbi.nlm.nih.gov/23881296","citation_count":15,"is_preprint":false},{"pmid":"23519094","id":"PMC_23519094","title":"Limk2 mediates semaphorin signalling in cortical interneurons migrating through the subpallium.","date":"2013","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/23519094","citation_count":13,"is_preprint":false},{"pmid":"30373762","id":"PMC_30373762","title":"LIMK2-1, a new isoform of human LIMK2, regulates actin cytoskeleton remodeling via a different signaling pathway than that of its two homologs, LIMK2a and LIMK2b.","date":"2018","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/30373762","citation_count":12,"is_preprint":false},{"pmid":"32141548","id":"PMC_32141548","title":"Metabolites of intestinal microflora upregulate miR-192-5p to suppress proliferation of colon cancer cells via RhoA-ROCK-LIMK2 pathway.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32141548","citation_count":11,"is_preprint":false},{"pmid":"37946061","id":"PMC_37946061","title":"Stratifin (SFN) Regulates Cervical Cancer Cell Proliferation, Apoptosis, and Cytoskeletal Remodeling and Metastasis Progression Through LIMK2/Cofilin Signaling.","date":"2023","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/37946061","citation_count":11,"is_preprint":false},{"pmid":"36922679","id":"PMC_36922679","title":"LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition.","date":"2023","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/36922679","citation_count":10,"is_preprint":false},{"pmid":"30870492","id":"PMC_30870492","title":"Chronic administration of LIMK2 inhibitors alleviates cavernosal veno-occlusive dysfunction through suppression of cavernosal fibrosis in a rat model of erectile dysfunction after cavernosal nerve injury.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30870492","citation_count":9,"is_preprint":false},{"pmid":"37141984","id":"PMC_37141984","title":"LIMK2: A Multifaceted kinase with pleiotropic roles in human physiology and pathologies.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/37141984","citation_count":8,"is_preprint":false},{"pmid":"31926945","id":"PMC_31926945","title":"LIM kinase 2 (LIMK2) may play an essential role in platelet function.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31926945","citation_count":8,"is_preprint":false},{"pmid":"35525325","id":"PMC_35525325","title":"Thromboxane A2 receptor activation via Gα13-RhoA/C-ROCK-LIMK2-dependent signal transduction inhibits angiogenic sprouting of human endothelial cells.","date":"2022","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35525325","citation_count":8,"is_preprint":false},{"pmid":"30594563","id":"PMC_30594563","title":"LIMK2-1 is a Hominidae-Specific Isoform of LIMK2 Expressed in Central Nervous System and Associated with Intellectual Disability.","date":"2018","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30594563","citation_count":5,"is_preprint":false},{"pmid":"33977398","id":"PMC_33977398","title":"Involvement of LIMK2 in actin cytoskeleton remodeling during the definitive endoderm differentiation.","date":"2021","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/33977398","citation_count":5,"is_preprint":false},{"pmid":"34353741","id":"PMC_34353741","title":"LIMK2 is required for membrane cytoskeleton reorganization of contracting airway smooth muscle.","date":"2021","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/34353741","citation_count":5,"is_preprint":false},{"pmid":"38580197","id":"PMC_38580197","title":"Decoding the tumour-modulatory roles of LIMK2.","date":"2024","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38580197","citation_count":4,"is_preprint":false},{"pmid":"32124389","id":"PMC_32124389","title":"mRNA level of ROCK1, RHOA, and LIMK2 as genes associated with apoptosis in evaluation of effectiveness of adalimumab treatment.","date":"2020","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/32124389","citation_count":4,"is_preprint":false},{"pmid":"39631222","id":"PMC_39631222","title":"Unveiling novel type 1 inhibitors for targeting LIM kinase 2 (LIMK2) for cancer therapeutics: An integrative pharmacoinformatics approach.","date":"2024","source":"Computational biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39631222","citation_count":3,"is_preprint":false},{"pmid":"37077345","id":"PMC_37077345","title":"NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2.","date":"2023","source":"Open life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37077345","citation_count":3,"is_preprint":false},{"pmid":"36330887","id":"PMC_36330887","title":"Function of connexin 43 and RhoA/LIMK2/Cofilin signaling pathway in transient changes of contraction and dilation of human umbilical arterial smooth muscle cells.","date":"2022","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36330887","citation_count":2,"is_preprint":false},{"pmid":"20193279","id":"PMC_20193279","title":"[Effects of LIMK2 RNA interference on the mechanosensitivity of c-fos gene in osteoblast].","date":"2009","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/20193279","citation_count":1,"is_preprint":false},{"pmid":"9556220","id":"PMC_9556220","title":"A sequence highly similar to PNG is located on chromosome 22q12 in intron 15 of the LIMK-2 gene.","date":"1998","source":"Biochemistry and molecular biology international","url":"https://pubmed.ncbi.nlm.nih.gov/9556220","citation_count":1,"is_preprint":false},{"pmid":"40775397","id":"PMC_40775397","title":"LIMK2 promotes centrosome clustering and cancer progression by activating MST4-mediated phosphorylation of NPM1.","date":"2025","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/40775397","citation_count":0,"is_preprint":false},{"pmid":"40806479","id":"PMC_40806479","title":"LIMK2-1 Is a Phosphorylation-Dependent Inhibitor of Protein Phosphatase-1 Catalytic Subunit and Myosin Phosphatase Holoenzyme.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40806479","citation_count":0,"is_preprint":false},{"pmid":"41680856","id":"PMC_41680856","title":"Ift46 deficiency causes renal cyst via enhanced Limk2 through lack of autophagy flux.","date":"2026","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/41680856","citation_count":0,"is_preprint":false},{"pmid":"41644972","id":"PMC_41644972","title":"LIMK2 inactivation suppresses mechanical stimulation-induced dermal fibroblast differentiation and resistance to apoptosis.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41644972","citation_count":0,"is_preprint":false},{"pmid":"38063080","id":"PMC_38063080","title":"Harnessing allosteric inhibition: prioritizing LIMK2 inhibitors for targeted cancer therapy through pharmacophore-based virtual screening and essential molecular dynamics.","date":"2023","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/38063080","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.17.649341","title":"Covalent targeting leads to the development of LIMK1 isoform-selective inhibitors","date":"2025-04-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.17.649341","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":33193,"output_tokens":6161,"usd":0.095997},"stage2":{"model":"claude-opus-4-6","input_tokens":9850,"output_tokens":3975,"usd":0.222938},"total_usd":0.318935,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"LIMK2 is a serine/threonine kinase with two N-terminal LIM motifs and a C-terminal kinase domain; it phosphorylates serine and threonine residues of exogenous substrates (e.g., myelin basic protein) in vitro, confirming its kinase activity.\",\n      \"method\": \"In vitro kinase assay with immunoprecipitated protein\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro kinase assay with immunoprecipitated protein, foundational study\",\n      \"pmids\": [\"7651734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Recombinant LIMK2 is autophosphorylated and exhibits serine/threonine kinase activity toward exogenous substrate MBP; endogenous LIMK2 co-precipitates with a 140 kDa tyrosine-phosphorylated protein; LIMK2 localizes to both nucleus and Triton X-100 soluble cytoplasmic fraction.\",\n      \"method\": \"In vitro kinase assay; co-immunoprecipitation; subcellular fractionation\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay plus Co-IP and fractionation in single study\",\n      \"pmids\": [\"9089416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"LIMK2a (with two LIM domains, PDZ domain, and kinase domain) is distributed in cytoplasm and nucleus, whereas LIMK2b (with one and a half LIM domains) is mainly cytoplasmic; a truncated LIMK2-Kinase construct localizes to the nucleus without showing protein association.\",\n      \"method\": \"Transfection and subcellular localization studies; Co-IP identifying associated 63 kDa and 58 kDa proteins\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct localization experiment with functional domain distinction and co-precipitation\",\n      \"pmids\": [\"8954941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LIMK2 is a downstream effector of the Rho-ROCK pathway; loss of neurofibromin activates Rho-ROCK-LIMK2 signaling, increasing cofilin phosphorylation and actin stress fiber formation, thereby enhancing cell motility. This pathway requires Ras activation but is independent of Raf, PI3K, and RalGEF.\",\n      \"method\": \"siRNA knockdown of NF1; immunofluorescence; western blotting; genetic epistasis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with multiple pathway branches tested, orthogonal methods, replicated pathway\",\n      \"pmids\": [\"16169856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PKC-delta phosphorylates LIMK2 at Ser-283 (between PDZ and kinase domains), inhibiting nuclear import of LIMK2 in endothelial cells; this is a mechanism to relieve LIMK2-mediated suppression of cyclin D1 expression and promote G1-to-S transition.\",\n      \"method\": \"EGFP-LIMK2 live imaging; FRAP; leptomycin B treatment; in vitro phosphorylation by PKC-delta; site-directed mutagenesis (Ser-283)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay with mutagenesis, live imaging, and FRAP in single study\",\n      \"pmids\": [\"15923181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"LIMK2 activity toward cofilin is markedly increased when cells are arrested in mitosis by microtubule disruption (nocodazole); LIMK2 localizes to the mitotic spindle during prometaphase and to the spindle midzone during anaphase/telophase, distinct from LIMK1's localization at spindle poles and the cleavage furrow.\",\n      \"method\": \"Immunofluorescence; cell synchronization with nocodazole; in vitro kinase assay\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct kinase assay plus immunofluorescence localization with cell-cycle synchronization\",\n      \"pmids\": [\"16455074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"LIMK2 is a direct p53 target gene induced by genotoxic agents; activation of LIMK2 downstream of the RhoC-p53 axis has a pro-survival function following DNA damage, and LIMK inhibition sensitizes cells to radio- or chemotherapy.\",\n      \"method\": \"siRNA knockdown; pharmacological inhibition; ChIP (p53 target gene identification); cell viability assays\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing p53 transcriptional regulation and functional consequence\",\n      \"pmids\": [\"21079653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Aurora A kinase directly phosphorylates LIMK2 at S283, T494, and T505, regulating LIMK2 kinase activity, subcellular localization, and protein levels; LIMK2 in turn positively regulates Aurora A levels (positive feedback loop); LIMK2 ablation fully abrogates Aurora-A-mediated tumorigenesis in vivo.\",\n      \"method\": \"Chemical genetic approach (analog-sensitive kinase); direct phosphorylation assays; site-directed mutagenesis; nude mouse xenograft\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — chemical genetics identifies direct substrate, mutagenesis confirms sites, in vivo validation\",\n      \"pmids\": [\"22492986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LIMK2 acts downstream of RhoA-ROCK in regulating astral microtubule organization through TPPP (not cofilin), while both LIMK1 and LIMK2 affect centrosome focusing; these activities regulate spindle orientation in mitotic cells.\",\n      \"method\": \"RNAi knockdown; immunofluorescence; epistasis analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with multiple pathway branches, clean KO phenotype with specific cellular readout\",\n      \"pmids\": [\"22328514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The NF1 RasGAP SecPH domain directly interacts with LIMK2 (but not LIMK1), partially inhibits LIMK2 kinase activity on cofilin, and specifically prevents LIMK2 activation by ROCK, establishing a cross-talk between Ras and Rho/ROCK/LIMK2/cofilin pathways.\",\n      \"method\": \"Yeast two-hybrid screen; co-immunoprecipitation; in vitro kinase assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — Y2H confirmed by Co-IP, mechanism tested by in vitro kinase assay, isoform specificity demonstrated\",\n      \"pmids\": [\"23082153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LIMK2 is required for keratinocyte migration during eyelid development in vivo; LIMK2 knockout mice show eyes-open-at-birth phenotype due to failure of leading keratinocytes to nucleate filamentous actin, associated with reduced phospho-cofilin levels.\",\n      \"method\": \"LIMK2 knockout mouse; histology; immunostaining for F-actin and phospho-cofilin\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific in vivo phenotype and biochemical substrate readout\",\n      \"pmids\": [\"23071748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"LIMK2 deletion increases gastrointestinal stem cell proliferation in mice and Drosophila, revealing a conserved role for LIMK2 in constraining gastrointestinal stem cell homeostasis.\",\n      \"method\": \"Limk2 knockout mice; Drosophila LIMK knockdown; histology; mouse cancer model\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined cellular phenotype, cross-species validation\",\n      \"pmids\": [\"23585469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Limk2 mediates Sema3A (but not Sema3F) signaling in cortical interneurons; Limk2 siRNA-transfected interneurons are less responsive to Sema3A, leading to aberrant invasion of the developing striatum.\",\n      \"method\": \"siRNA knockdown; chemotactic assays; brain slice preparation; in utero electroporation\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo electroporation and slice assays, multiple readouts, single lab\",\n      \"pmids\": [\"23519094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ROCK1 directly interacts with LIMK2 (preferred substrate for ROCK1) in polarized/spread cancer cells but not in blebbing cells, as demonstrated by FRET; LIMK2 does not induce membrane blebbing, indicating the ROCK1:LIMK2 pathway is specific to mesenchymal-mode migration.\",\n      \"method\": \"FRET; Co-IP; functional migration assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal FRET and Co-IP demonstrating direct interaction with spatial specificity\",\n      \"pmids\": [\"18852895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"LIMK2 directly phosphorylates TWIST1, stabilizing it; TWIST1 also stabilizes LIMK2 by inhibiting its ubiquitylation; phosphorylation-dead TWIST1 acts as dominant negative and prevents EMT and tumor formation in vivo, establishing LIMK2-TWIST1 as a signaling axis in CRPC.\",\n      \"method\": \"In vitro phosphorylation; dominant-negative mutant; in vivo xenograft; ubiquitylation assay\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct phosphorylation assay, dominant-negative validation, in vivo confirmation\",\n      \"pmids\": [\"30716360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LIMK2 phosphorylates PTEN at five sites, promoting its degradation and inhibiting its activity; PTEN in turn degrades LIMK2 in a feedback loop; LIMK2 is the missing link between hypoxia and PTEN degradation in CRPC.\",\n      \"method\": \"In vitro phosphorylation; site mapping; PTEN-/- and PTEN+/+ mouse prostates; xenograft\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct phosphorylation assay with site identification, confirmed in PTEN KO mice\",\n      \"pmids\": [\"32931887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LIMK2 directly phosphorylates and degrades SPOP (E3 ubiquitin ligase adaptor) at three sites; SPOP in turn promotes LIMK2 ubiquitylation (feedback loop); SPOP degradation stabilizes AR, ARv7, and c-Myc; phospho-resistant SPOP completely suppresses tumorigenesis in vivo.\",\n      \"method\": \"Innovative direct target identification technique; in vitro phosphorylation; ubiquitylation assay; xenograft\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct phosphorylation with site mapping, phospho-resistant mutant, in vivo validation\",\n      \"pmids\": [\"33311589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NKX3.1 is directly phosphorylated and degraded by LIMK2; NKX3.1 in turn promotes LIMK2 ubiquitylation; this LIMK2-NKX3.1 feedback loop regulates AR, ARv7, and AKT signaling in CRPC.\",\n      \"method\": \"Direct phosphorylation assay; ubiquitylation assay; in vivo xenograft; biochemical assays\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct phosphorylation with feedback loop demonstrated, in vivo validation\",\n      \"pmids\": [\"34066036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LIMK2 promotes TNBC metastasis through phosphorylation and activation of SRPK1 (serine/arginine protein kinase); LIMK2 inhibition blocks SRPK1 phosphorylation and activity, and pharmacological inhibition of LIMK2 blocks metastasis in mice without affecting primary tumor growth.\",\n      \"method\": \"SILAC-based phosphoproteomics; shRNA knockdown; pharmacological inhibition; in vivo metastasis model\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — unbiased phosphoproteomics identifies substrate, confirmed by genetic/pharmacological inhibition in vivo\",\n      \"pmids\": [\"32859889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The LIMK2-1 isoform contains a PP1 inhibitory domain at its C-terminus; it does not directly phosphorylate cofilin but interacts with PP1 and partially inhibits its activity toward cofilin, regulating actin cytoskeleton dynamics by preventing PP1-mediated cofilin dephosphorylation.\",\n      \"method\": \"Biochemical characterization; in vitro kinase assay; Co-IP with PP1; actin stress fiber assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay demonstrates absence of cofilin phosphorylation, Co-IP demonstrates PP1 interaction, mechanistic alternative established\",\n      \"pmids\": [\"30373762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"LIMK1 and LIMK2 regulate cortical development by controlling neural progenitor cell proliferation and neuronal migration; LIMK2 KO mice show reduced pyramidal neurons in upper cortical layers with a smaller progenitor pool and impaired neuronal migration.\",\n      \"method\": \"LIMK2 knockout mice; histology; cell counting\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific developmental phenotype, single lab\",\n      \"pmids\": [\"31319858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LIMK2 is required for membrane cytoskeleton reorganization in airway smooth muscle; LIMK2 deletion causes ~30% inhibition of contractile force, reduced cofilin phosphorylation, decreased F/G-actin ratio, and abolishes stretching-induced suppression of 5-HT-evoked force; LIMK2 acts independently of cross-bridge movement.\",\n      \"method\": \"LIMK2 knockout mice; force transduction assays; F/G-actin ratio measurement; western blotting\",\n      \"journal\": \"Journal of genetics and genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with quantitative functional readout and biochemical substrate measurement\",\n      \"pmids\": [\"34353741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Endothelin-1 acts upstream of LIMK2 via ETB receptor and ROCK1 to induce programmed necrotic neuronal death; ET-1/ETB/ROCK1/LIMK2 signaling impairs DRP1-mediated mitochondrial fission, leading to neuronal necrosis.\",\n      \"method\": \"ETB receptor antagonist (BQ788); western blotting; in vivo status epilepticus model\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological antagonism defines pathway position, in vivo model, single lab\",\n      \"pmids\": [\"26438559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BMPR2 directly interacts with LIMK2 and activates it through the RhoA/ROCK pathway; LIMK2 phosphorylation by BMPR2 is crucial for BMPR2-mediated pro-metastatic signaling in osteosarcoma cells.\",\n      \"method\": \"iTRAQ-based phosphoproteomic analysis; western blotting; Co-IP (direct interaction); in vivo orthotopic model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP for direct interaction, phosphoproteomics, in vivo validation, single lab\",\n      \"pmids\": [\"28938584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"LIMK2 phosphorylates MST4 at threonine 178 (T178), activating its kinase function; activated MST4 then phosphorylates NPM1 at T95, which is essential for centrosome clustering and tumor cell proliferation; LIMK2 knockout significantly attenuates esophageal tumorigenesis in vivo.\",\n      \"method\": \"In vitro kinase assay; site-specific mutagenesis; genetic depletion; in vivo 4NQO tumorigenesis model; pharmacological inhibition\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct phosphorylation with site identification, cascade confirmed, in vivo validation\",\n      \"pmids\": [\"40775397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"LIMK2-1 isoform is phosphorylated predominantly by protein kinase C; phosphorylated LIMK2-1 inhibits PP1 catalytic subunit isoforms and the myosin phosphatase holoenzyme with IC50 ~28–47 nM, functioning as a CPI-17-like phosphatase inhibitor.\",\n      \"method\": \"Co-IP with PP1c isoforms; in vitro phosphatase inhibition assay; overexpression in tsA201 cells\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted phosphatase inhibition assay with IC50 determination, Co-IP confirms interaction\",\n      \"pmids\": [\"40806479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LIMK2a knockout mice show prolonged bleeding and defects in platelet spreading, aggregation, and thrombus formation, demonstrating an essential role for LIMK2 in platelet actin cytoskeleton-dependent functions.\",\n      \"method\": \"LIMK2a knockout mouse; bleeding time assay; platelet spreading assay; aggregation assay\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean isoform-specific KO with defined platelet functional phenotype, single lab\",\n      \"pmids\": [\"31926945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LIMK2 phosphorylates G3BP1 as a key direct substrate; G3BP1 inhibition mirrors LIMK2 inhibition; G3BP1 regulates ESM1 mRNA stability downstream, defining a LIMK2→G3BP1→ESM1 pathway promoting melanoma growth and metastasis.\",\n      \"method\": \"Phosphoproteomics; shRNA knockdown; RNA-seq; mRNA stability assay; in vivo tumor model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — phosphoproteomics identifies substrate, cascade validated by genetic tools and in vivo model\",\n      \"pmids\": [\"36922679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Thromboxane A2 receptor activation signals through Gα13-RhoA/C-ROCK-LIMK2 to inhibit angiogenic sprouting of endothelial cells and induce endothelial cell contraction, tension, and focal adhesion dysregulation.\",\n      \"method\": \"RNAi-mediated silencing; pharmacological inhibition; FRET biosensors for RhoA/C; HUVEC spheroid sprouting assay\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway established by RNAi epistasis plus FRET validation, single lab\",\n      \"pmids\": [\"35525325\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LIMK2 is a serine/threonine kinase that acts downstream of RhoA-ROCK (and other upstream kinases including Aurora A and PKC-delta) to phosphorylate cofilin (inactivating it to stabilize actin filaments), and also directly phosphorylates multiple non-cofilin substrates including TWIST1, PTEN, SPOP, NKX3.1, SRPK1, G3BP1, and MST4, while its LIMK2-1 isoform instead inhibits PP1/myosin phosphatase; its subcellular localization and nuclear import are regulated by PKC-delta-mediated phosphorylation at Ser-283, and it plays defined roles in cell migration, mitotic spindle organization, gastrointestinal stem cell homeostasis, neuronal migration, platelet function, and airway smooth muscle contraction.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"LIMK2 is a LIM-domain-containing serine/threonine kinase that functions as a central integrator of Rho-ROCK, Aurora A, and PKC-δ signaling to regulate actin cytoskeleton dynamics, mitotic spindle organization, cell migration, and diverse transcriptional and signaling outputs. Its best-characterized activity is phosphorylation and inactivation of cofilin, which stabilizes F-actin and is required for keratinocyte migration, platelet function, airway smooth muscle contraction, cortical neuronal migration, and gastrointestinal stem cell homeostasis [PMID:23071748, PMID:31926945, PMID:34353741, PMID:31319858, PMID:23585469]. Beyond cofilin, LIMK2 directly phosphorylates substrates including TWIST1, PTEN, SPOP, NKX3.1, SRPK1, G3BP1, and MST4—often engaging in reciprocal feedback loops that control substrate stability—thereby driving epithelial-mesenchymal transition, androgen receptor signaling in castration-resistant prostate cancer, metastasis, and centrosome clustering [PMID:30716360, PMID:32931887, PMID:33311589, PMID:32859889, PMID:36922679, PMID:40775397]. The LIMK2-1 splice isoform lacks direct cofilin kinase activity and instead functions as a potent CPI-17-like inhibitor of PP1/myosin phosphatase upon PKC-mediated phosphorylation, providing an alternative mechanism for cytoskeletal regulation [PMID:30373762, PMID:40806479].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing LIMK2 as a bona fide serine/threonine kinase answered the fundamental question of whether this LIM-domain protein possessed intrinsic catalytic activity.\",\n      \"evidence\": \"In vitro kinase assay with immunoprecipitated LIMK2 phosphorylating MBP\",\n      \"pmids\": [\"7651734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological substrates unidentified\", \"Upstream activators unknown\", \"Relationship to actin cytoskeleton not established\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Isoform-specific localization studies revealed that the LIM/PDZ domains control cytoplasmic vs. nuclear distribution, establishing that LIMK2 functions in multiple subcellular compartments.\",\n      \"evidence\": \"Transfection and localization of LIMK2a, LIMK2b, and kinase-only constructs with Co-IP\",\n      \"pmids\": [\"8954941\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear function undefined\", \"Nuclear import mechanism unknown\", \"Associated proteins at 63/58 kDa unidentified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Placing LIMK2 downstream of Rho-ROCK in a cofilin-phosphorylating cascade resolved its principal physiological pathway and linked it to actin stress fiber formation and cell motility.\",\n      \"evidence\": \"siRNA knockdown of NF1 with epistasis analysis separating Ras-Raf/PI3K/RalGEF from Rho-ROCK-LIMK2\",\n      \"pmids\": [\"16169856\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ROCK-LIMK2 phosphorylation sites not mapped\", \"Non-cofilin substrates unknown\", \"In vivo relevance not demonstrated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery that PKC-δ phosphorylates LIMK2 at Ser-283 to block nuclear import established a regulated mechanism for controlling LIMK2 subcellular distribution and cell cycle progression.\",\n      \"evidence\": \"In vitro phosphorylation by PKC-δ; Ser-283 mutagenesis; FRAP and live imaging of EGFP-LIMK2\",\n      \"pmids\": [\"15923181\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear substrates of LIMK2 not identified beyond cyclin D1 regulation\", \"Whether Ser-283 phosphorylation affects kinase activity per se untested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstration that LIMK2 localizes to the mitotic spindle and spindle midzone with increased cofilin kinase activity during mitosis extended its role beyond interphase actin regulation to cell division.\",\n      \"evidence\": \"Immunofluorescence with cell-cycle synchronization; in vitro kinase assay on mitotic extracts\",\n      \"pmids\": [\"16455074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mitotic LIMK2 activating kinase not identified at this point\", \"Whether spindle localization requires cofilin phosphorylation unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"FRET-based demonstration that ROCK1 preferentially interacts with LIMK2 in polarized/spread cells showed the ROCK1–LIMK2 axis is specific to mesenchymal-mode migration, not blebbing.\",\n      \"evidence\": \"FRET and Co-IP in cancer cells with distinct morphological modes\",\n      \"pmids\": [\"18852895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ROCK2 vs. ROCK1 selectivity for LIMK2 not fully resolved\", \"Structural basis of mesenchymal-specific interaction unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of LIMK2 as a direct p53 target gene linked cytoskeletal remodeling to the DNA damage response, revealing a pro-survival role for LIMK2 after genotoxic stress.\",\n      \"evidence\": \"ChIP confirming p53 occupancy at LIMK2 promoter; siRNA and pharmacological inhibition sensitizing cells to radio/chemotherapy\",\n      \"pmids\": [\"21079653\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise p53-binding element not fine-mapped\", \"Whether cofilin is the relevant substrate in this survival context unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Multiple studies converged to define LIMK2's in vivo roles: Aurora A directly phosphorylates and activates LIMK2 creating a positive feedback loop essential for tumorigenesis; LIMK2 regulates astral microtubules through TPPP; NF1 SecPH domain specifically inhibits LIMK2 (not LIMK1); and LIMK2 knockout causes eyes-open-at-birth due to failed keratinocyte migration.\",\n      \"evidence\": \"Chemical genetics (Aurora A analog-sensitive kinase); RNAi epistasis for TPPP; Y2H/Co-IP for NF1-LIMK2; LIMK2 knockout mouse phenotyping\",\n      \"pmids\": [\"22492986\", \"22328514\", \"23082153\", \"23071748\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Aurora A and ROCK phosphorylation of LIMK2 are cooperative or competitive\", \"TPPP phosphorylation by LIMK2 not directly demonstrated\", \"Structural basis of NF1 SecPH selectivity for LIMK2 over LIMK1 unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Loss-of-function studies in mice and Drosophila revealed a conserved role for LIMK2 in restraining gastrointestinal stem cell proliferation, and LIMK2 was shown to mediate Sema3A signaling in cortical interneurons for proper neuronal migration.\",\n      \"evidence\": \"LIMK2 knockout mice and Drosophila LIMK knockdown for GI homeostasis; siRNA and in utero electroporation for neuronal migration\",\n      \"pmids\": [\"23585469\", \"23519094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream substrate in GI stem cells not identified\", \"Whether cofilin or another substrate mediates Sema3A response unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Characterization of the LIMK2-1 splice isoform revealed it lacks cofilin kinase activity and instead functions as a PP1 inhibitor, providing an entirely distinct mechanism for cytoskeletal regulation.\",\n      \"evidence\": \"In vitro kinase assay showing no cofilin phosphorylation; Co-IP with PP1; actin stress fiber assay\",\n      \"pmids\": [\"30373762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue distribution and expression ratio of LIMK2-1 vs. other isoforms incompletely defined\", \"PP1 inhibitory domain not structurally characterized\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of TWIST1 as a direct LIMK2 substrate that reciprocally stabilizes LIMK2 revealed a kinase-transcription factor feedback axis driving EMT in castration-resistant prostate cancer.\",\n      \"evidence\": \"In vitro phosphorylation; phosphorylation-dead dominant-negative TWIST1; xenograft tumor assays\",\n      \"pmids\": [\"30716360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific TWIST1 phosphorylation sites by LIMK2 not fully mapped\", \"Whether this axis operates outside prostate cancer untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"A burst of substrate discovery established LIMK2 as a multi-substrate kinase: it phosphorylates and degrades PTEN and SPOP (each in feedback loops), activates SRPK1 to promote metastasis, and is required for platelet function in vivo.\",\n      \"evidence\": \"Direct in vitro phosphorylation with site mapping for PTEN and SPOP; SILAC phosphoproteomics for SRPK1; LIMK2a knockout mouse for platelet assays\",\n      \"pmids\": [\"32931887\", \"33311589\", \"32859889\", \"31926945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How LIMK2 substrate selectivity is determined (cofilin vs. non-cofilin targets) unknown\", \"Whether PTEN/SPOP regulation occurs in non-prostate tissues untested\", \"Platelet phenotype rescue experiments not performed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"NKX3.1 was added as another LIMK2 substrate in a mutual degradation loop regulating AR signaling, while LIMK2 knockout studies demonstrated its requirement for airway smooth muscle contraction through cofilin-dependent actin remodeling.\",\n      \"evidence\": \"Direct phosphorylation and ubiquitylation assays for NKX3.1; LIMK2 KO mouse force transduction and F/G-actin ratio measurements\",\n      \"pmids\": [\"34066036\", \"34353741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LIMK2 regulation of AR signaling depends on NKX3.1 phosphorylation alone or also on SPOP/PTEN degradation\", \"Mechanism connecting cofilin to smooth muscle actin polymerization vs. myosin regulation not delineated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Phosphoproteomic identification of G3BP1 as a LIMK2 substrate linked LIMK2 to mRNA stability regulation through a LIMK2→G3BP1→ESM1 axis in melanoma.\",\n      \"evidence\": \"Phosphoproteomics; shRNA; RNA-seq; mRNA stability assay; in vivo melanoma model\",\n      \"pmids\": [\"36922679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether G3BP1 phosphorylation by LIMK2 affects stress granule dynamics untested\", \"Broader RNA targets beyond ESM1 not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that LIMK2 phosphorylates MST4 at T178 to activate a MST4→NPM1 cascade for centrosome clustering revealed a new mechanism for LIMK2-driven tumor proliferation, while quantitative IC50 measurements established LIMK2-1 as a nanomolar-potency myosin phosphatase inhibitor.\",\n      \"evidence\": \"In vitro kinase assay with site-specific mutagenesis and in vivo esophageal tumorigenesis model for MST4; reconstituted phosphatase inhibition assay with IC50 for LIMK2-1\",\n      \"pmids\": [\"40775397\", \"40806479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LIMK2-MST4-NPM1 operates in non-esophageal cancers untested\", \"Relative contribution of LIMK2-1 PP1 inhibition vs. canonical LIMK2 cofilin phosphorylation in vivo unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How LIMK2 achieves substrate selectivity among its numerous substrates (cofilin, TWIST1, PTEN, SPOP, NKX3.1, SRPK1, G3BP1, MST4), whether there is a unifying structural or scaffold-based mechanism, and how isoform-specific functions (LIMK2a kinase vs. LIMK2-1 phosphatase inhibitor) are coordinated in vivo remain major open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of LIMK2 in complex with any substrate\", \"Isoform expression ratio across tissues not systematically mapped\", \"No comprehensive phosphosite atlas of LIMK2 autophosphorylation or upstream regulation\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 3, 5, 7, 14, 15, 16, 17, 18, 24, 27]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [19, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2, 4]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [5, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 8, 9, 13, 22, 23, 28]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5, 7, 8, 24]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10, 12, 20]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [22]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [14, 15, 16, 17, 18, 27]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CFL1\",\n      \"ROCK1\",\n      \"AURKA\",\n      \"TWIST1\",\n      \"PTEN\",\n      \"SPOP\",\n      \"PPP1CA\",\n      \"NF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}